Biomarkers in endometrial cancer: Possible clinical applications (Review)
نویسندگان
چکیده
منابع مشابه
Biomarkers in endometrial cancer: Possible clinical applications (Review).
The number of cases of endometrial cancer has shown a tendency to increase in recent years. Endometrial cancer originates from the endometrium and is classified, based on the development mechanism, into types 1 and 2, which are responsive and non-responsive to estrogen, respectively, and have significantly different gene expression profiles. Studies of genes with abnormal expression in endometr...
متن کاملEpigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
Improvements in epigenetics have resulted in identification of a number of genes with aberrant hypermethylation associated with systematic occurrence of cancer. It is now evident that aberrant hypermethylation inactivates cancer-related genes including those associated with cell cycle control, apoptosis, and DNA repair. An epigenetic analysis of DNA hypermethylation in type I endometrial cancer...
متن کاملA review of biomarkers in the diagnosis of bladder cancer
Bladder cancer is among the ten most common cancers and the ten main causes of cancer-related deaths in the world. Currently, bladder tumors are diagnosed and followed up using a combination of cystoscopy and cytology. In addition, bladder cancer often recurs and can progress if not closely monitored after initial treatment. Constant monitoring of the patient with cystoscopy, which is an invasi...
متن کاملMicroRNAS in endometrial cancer: recent advances and potential clinical applications
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are useful for early and accurate diagnosis and few treatments other than surgery. However, use of microRNAs (miRNAs) that induces gene downregulation in cells may permit effective and minimally invasive diagnosis and treatment. In endometrial cancer cells, expression levels of miRNAs including miR-1...
متن کاملEmerging Therapeutic Biomarkers in Endometrial Cancer
Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth factor) in endometrial cancer show modest effects, there are still challenges that might remain regarding primary/acquired drug resistance and unexpected side effects on normal tissues. New studies that aim to t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology Letters
سال: 2012
ISSN: 1792-1074,1792-1082
DOI: 10.3892/ol.2012.654